Jerome Taylor, M.D. Child, Adolescent, and Adult Psychiatrist
Dr. Taylor is a child, adolescent and adult psychiatrist interested in developing interventions to prevent schizophrenia and other illnesses with psychotic features, like bipolar. He is also interested in the biological mechanisms underlying the “conversion” from being a youth at high risk for psychosis (e.g. a child or adolescent who has a family member with schizophrenia or bipolar) to a youth with a fulminant psychotic disorder. He is particularly interested in the roles neuroinflammation, oxidative stress and sleep play in "conversion to psychosis." Dr. Taylor has received multiple awards and grants for his research including the National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant, the American Academy of Child and Adolescent Psychiatry (AACAP) Pilot Research Award and the American Psychiatric Association - Substance Abuse and Mental Health Services Administration (APA/SAMHSA) Minority Fellowship. He is a Contributing Editor for the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP).
Clinically, Dr. Taylor is committed to providing mental healthcare to under-resourced, minority and LGBTQI communities.
Dr. Taylor completed his psychiatry residency and child and adolescent psychiatry fellowship at Yale, where he was Chief Resident. At Yale, he conducted clinical research focusing on anxiety and obesity. He received his M.D. from the University of Virginia, completed an Epidemiology Fellowship at the Centers for Disease Control and Prevention and graduated summa cum laude from Rice University with a B.A. in Biochemistry and Cell Biology.
- Taylor JH*, Calkins ME*, Gur RE. Markers of psychosis risk in the general population. Biological Psychiatry. 2020 (In Press). PMID: 32220500. (*authors contributed equally)
- Taylor JH, Asabere N, Calkins ME, Moore TM, Tang SX, Xavier R, Merikangas AK, Wolf DH, Almasy L, Gur RC, Gur RE. Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort. Schizophrenia Research. 2020 (In Press). PMID: 31883930.
- Taylor JH, Jakubovski E, Gabriel D, Bloch MH. Predictors and moderators of antipsychotic-related weight gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study. Journal of Child and Adolescent Psychopharmacology. 2018;28(7):474-484. PMID: 29920116.
- Taylor JH, Lebowitz ER, Jakubovski E, Coughlin CG, Silverman WK, Bloch MH. Monotherapy insufficient in severe anxiety? Predictors and moderators in the Child/Adolescent Anxiety Multimodal Study. Journal of Clinical Child & Adolescent Psychology. 2018;47(2):266-281. PMID: 28956620. (Featured on NPR.org and selected as Brain and Behavior Research Foundation Top Ten Research Achievement of 2017).
- Taylor JH, Landeros-Weisenberger A, Coughlin CG, Mulqueen J, Johnson JA, Gabriel D, Reed MO, Jakubovski E, Bloch MH. Ketamine for social anxiety disorder: a randomized placebo-controlled crossover trial. Neuropsychopharmacology. 2018;43:325-333. PMID: 28849779. (Featured on Vice.com and several other media outlets)
- Taylor JH, Xu Y, Li F, Shaw M, Dzuria J, Caprio S, Tamborlane W, Nowicka P, Savoye M. Psychosocial predictors and moderators of weight management programme outcomes in ethnically-diverse obese youth. Pediatric Obesity. 2017;12:431-510. PMID: 27384496.
- Taylor JH, Jakubovski E, Bloch MH. Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial. Journal of Psychiatric Research. 2015;65:154-165. PMID: 25896121.
- Taylor J, Belay B, Park S, Onufrak S, Dietz W. Association of church-sponsored activity participation and prevalence of overweight and obesity in African-American Protestants, National Survey of American Life, 2001-2003. Ethnicity & Disease. 2013;23(3):322-328. PMID: 23914418.